Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V E Velculescu

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Science (New York, N.Y.)|December 28, 1999
Essay: Amersham Pharmacia Biotech & Science prize. Tantalizing transcriptomes--SAGE and its use in global gene expression analysisV E Velculescu
Oncogene|October 10, 2006
Implications of micro-RNA profiling for cancer diagnosisJ M Cummins, V E Velculescu
Clinical Chemistry|June 1, 1996
Biological and clinical importance of the p53 tumor suppressor geneV E Velculescu, W S El-Deiry
Trends in Genetics : TIG|October 26, 2000
Analysing uncharted transcriptomes with SAGEV E Velculescu, B Vogelstein, K W Kinzler
The Journal of Biological Chemistry|April 22, 1994
Receptor extracellular domains may contain trafficking information. Studies of the 300-kDa mannose 6-phosphate receptorS M Dintzis, V E Velculescu, S R Pfeffer
Science (New York, N.Y.)|October 20, 1995
Serial analysis of gene expressionV E Velculescu, L Zhang, B Vogelstein, et al.
Molecular and Cellular Biology|September 22, 1999
NORF5/HUG1 is a component of the MEC1-mediated checkpoint response to DNA damage and replication arrest in Saccharomyces cerevisiaeM A Basrai, V E Velculescu, K W Kinzler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2022
HLA class II immunogenic mutation burden predicts response to immune checkpoint blockadeX M Shao, J Huang, N Niknafs, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2023
Corrigendum to "HLA class II immunogenic mutation burden predicts response to immune checkpoint blockade": [Annals of Oncology volume 33 (2022) 728-738]X M Shao, J Huang, N Niknafs, et al.
Science (New York, N.Y.)|May 23, 1997
Gene expression profiles in normal and cancer cellsL Zhang, W Zhou, V E Velculescu, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Science (New York, N.Y.)|December 28, 1999
Essay: Amersham Pharmacia Biotech & Science prize. Tantalizing transcriptomes--SAGE and its use in global gene expression analysisV E Velculescu
Oncogene|October 10, 2006
Implications of micro-RNA profiling for cancer diagnosisJ M Cummins, V E Velculescu
Clinical Chemistry|June 1, 1996
Biological and clinical importance of the p53 tumor suppressor geneV E Velculescu, W S El-Deiry
Trends in Genetics : TIG|October 26, 2000
Analysing uncharted transcriptomes with SAGEV E Velculescu, B Vogelstein, K W Kinzler
The Journal of Biological Chemistry|April 22, 1994
Receptor extracellular domains may contain trafficking information. Studies of the 300-kDa mannose 6-phosphate receptorS M Dintzis, V E Velculescu, S R Pfeffer
Science (New York, N.Y.)|October 20, 1995
Serial analysis of gene expressionV E Velculescu, L Zhang, B Vogelstein, et al.
Molecular and Cellular Biology|September 22, 1999
NORF5/HUG1 is a component of the MEC1-mediated checkpoint response to DNA damage and replication arrest in Saccharomyces cerevisiaeM A Basrai, V E Velculescu, K W Kinzler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2022
HLA class II immunogenic mutation burden predicts response to immune checkpoint blockadeX M Shao, J Huang, N Niknafs, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2023
Corrigendum to "HLA class II immunogenic mutation burden predicts response to immune checkpoint blockade": [Annals of Oncology volume 33 (2022) 728-738]X M Shao, J Huang, N Niknafs, et al.
Science (New York, N.Y.)|May 23, 1997
Gene expression profiles in normal and cancer cellsL Zhang, W Zhou, V E Velculescu, et al.
Pageof 3